Miriam Ender
Overview
Explore the profile of Miriam Ender including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruprecht R, Suter R, Manganelli M, Wehrli A, Ender M, Jung B
Forensic Sci Int
. 2021 Dec;
330:111123.
PMID: 34883300
The commonly applied method for the examination of self-adhesive stamps mainly focuses on DNA-profiling while neglecting potential fingerprint evidence. In our preliminary study it was shown that in an uncontrolled...
2.
Ender M, Andreoni F, Zinkernagel A, Schuepbach R
PLoS One
. 2013 Nov;
8(11):e81298.
PMID: 24278414
Background: The family of 4 related protease-activated receptors (PAR-1, 2, 3 & 4) expressed by mammalian cells allow to sense for and react to extracellular proteolytic activity. Since major human...
3.
Cattepoel S, Schaub A, Ender M, Gaida A, Kropf A, Guggisberg U, et al.
PLoS One
. 2013 May;
8(5):e63162.
PMID: 23696796
Intravenous Immunoglobulin (IVIG) has been proposed as a potential therapeutic for Alzheimer's disease (AD) and its efficacy is currently being tested in mild-to-moderate AD. Earlier studies reported the presence of...
4.
Uchiyama S, Andreoni F, Zurcher C, Schilcher K, Ender M, Madon J, et al.
J Mol Med (Berl)
. 2013 Feb;
91(7):861-9.
PMID: 23443671
Group A Streptococcus (GAS) is a human pathogen causing a wide range of mild to severe and life-threatening diseases. The GAS M1 protein is a major virulence factor promoting GAS...
5.
Ender M, Berger-Bachi B, McCallum N
BMC Microbiol
. 2009 Jan;
9:15.
PMID: 19173709
Background: Methicillin resistance in Staphylococcus aureus is conferred by the mecA-encoded penicillin-binding protein PBP2a. Additional genomic factors are also known to influence resistance levels in strain specific ways, although little...
6.
Ender M, McCallum N, Berger-Bachi B
Int J Med Microbiol
. 2008 May;
298(7-8):607-17.
PMID: 18456552
The reason for the extremely low-level oxacillin resistance in a so-called 'drug clone', a methicillin-resistant Staphylococcus aureus circulating among injection drug users in Zurich, Switzerland, could be traced back to...
7.
Ender M, Berger-Bachi B, McCallum N
BMC Microbiol
. 2007 Jul;
7:62.
PMID: 17605795
Background: An extremely low level methicillin resistant Staphylococcus aureus (MRSA) belonging to ST45, circulates among intravenous drug users in the Zurich area. This clone can be misinterpreted as an MSSA...
8.
Lee S, Ender M, Adhikari R, Smith J, Berger-Bachi B, Cook G
Antimicrob Agents Chemother
. 2007 Feb;
51(4):1497-9.
PMID: 17283194
We examined the effect of introducing type I or IV staphylococcal cassette chromosome mec (SCCmec) elements on the growth yield of Staphylococcus aureus in glucose-limited continuous culture. Type I showed...
9.
Qi W, Ender M, OBrien F, Imhof A, Ruef C, McCallum N, et al.
J Clin Microbiol
. 2005 Oct;
43(10):5164-70.
PMID: 16207979
The majority of methicillin-resistant Staphylococcus aureus (MRSA) isolates, recovered in 2003 at the Department of Medical Microbiology in Zürich, Switzerland, belonged to major clones that are circulating worldwide. Staphylococcal cassette...
10.
Ender M, McCallum N, Adhikari R, Berger-Bachi B
Antimicrob Agents Chemother
. 2004 May;
48(6):2295-7.
PMID: 15155238
Transformation of a type I SCCmec element into Staphylococcus aureus yielded highly oxacillin-resistant transformants with a reduced growth rate. Faster-growing variants could again be selected at the cost of reduced...